H
Hangzhou DAC Biotech Co., Ltd
Innovative ADC drug development and commercialization for advanced medical solutions
About Hangzhou DAC Biotech Co., Ltd
DAC Biotech is a pioneering company in the research, development, production, and commercialization of Antibody-Drug Conjugates (ADC) drugs. Founded by a team of high-level entrepreneurs in collaboration with Zhejiang pharmaceutical companies and investment agencies, DAC Biotech operates in the biotechnology and pharmaceutical sectors. The core technical team comprises five Ph.D. holders, along with masters, bachelors, and specialists in technology development, technical advice, and result transfer. The company focuses on creating advanced medical solutions through cutting-edge biotechnology and medical technology. DAC Biotech serves pharmaceutical companies, healthcare providers, and research institutions, offering innovative ADC drugs that target specific diseases with high precision. The business model revolves around the development and commercialization of these specialized drugs, generating revenue through partnerships, licensing agreements, and direct sales.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | May 2021 | $156M | $624M | CITIC Capital · GL Ventures · CDG Invest Growth · CITIC PE | ↗ |
| SERIES BOther financing | Sep 2019 | $0 | — | Bangsheng Capital | — |
Growth signals
Latest recorded traffic for Hangzhou DAC Biotech Co., Ltd is 1.9K monthly website visits, up 72.7% over the last three months. Hangzhou DAC Biotech Co., Ltd's team grew 33.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Hangzhou DAC Biotech Co., Ltd in the Hangzhou ecosystem
The Hangzhou DAC Biotech Co., Ltd office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Addor Capital
- BPBetta Pharmaceuticals
- ZMZJKF Capital Management
Series A2 investors entered at this stage
- HYHuahai Yaoye
- BCBangsheng Capital
Series B and later4 investors entered at this stage
CITIC PE
CITIC Capital
GL Ventures
CDG Invest Growth
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Hangzhou DAC Biotech Co., Ltd on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Hangzhou DAC Biotech Co., Ltd’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









